ConductScience.org, home

Gene · 55872

Papers1,726

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

141 to 160 of 1,726

Download this page as JSON
TitleJournalYearPMIDFound bySource
Necessary Role of Ceramides in the Human Microvascular Endothelium During Health and Disease.Circ Res202438037825PubTator, text miningPubMed
A prognostic four-gene signature and a therapeutic strategy for hepatocellular carcinoma: Construction and analysis of a circRNA-mediated competing endogenous RNA network.Hepatobiliary Pancreat Dis Int202437407412PubTator, text miningPubMed
Token Sparsification for Faster Medical Image Segmentation.Inf Process Med Imaging202338680428PubTator, text miningPubMed
Characterization of CD4+ and CD8+ T cells responses in the mixed lymphocyte reaction by flow cytometry and single cell RNA sequencing.Front Immunol202338283342PubTator, text miningPubMed
Editorial: The role of tumor microenvironment in the development, treatment and prognosis of hepatocellular carcinoma.Front Pharmacol202338239197PubTator, text miningPubMed
Natural Chalcones and Derivatives in Colon Cancer: Pre-Clinical Challenges and the Promise of Chalcone-Based Nanoparticles.Pharmaceutics202338140059PubTator, text miningPubMed
The Potential Role of Gossypetin in the Treatment of Diabetes Mellitus and Its Associated Complications: A Review.Int J Mol Sci202338139436PubTator, text miningPubMed
Adipose Tissue, Non-Communicable Diseases, and Physical Exercise: An Imperfect Triangle.Int J Mol Sci202338138997PubTator, text miningPubMed
The Mechanism of Ubiquitination or Deubiquitination Modifications in Regulating Solid Tumor Radiosensitivity.Biomedicines202338137461PubTator, text miningPubMed
Preparation and investigation of a novel combination of Solanum nigrum-loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: in vitro, in vivo, and in silico evaluation.
Front Pharmacol202338125886PubTator, text miningPubMed
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor.J Exp Clin Cancer Res202338124207PubTator, text miningPubMed
Targeting CRAF kinase in anti-cancer therapy: progress and opportunities.Mol Cancer202338111008PubTator, text miningPubMed
Crowdsourcing temporal transcriptomic coronavirus host infection data: Resources, guide, and novel insights.Biol Methods Protoc202338107402PubTator, text miningPubMed
Integrated omics landscape of hepatocellular carcinoma suggests proteomic subtypes for precision therapy.Cell Rep Med202338091986PubTator, text miningPubMed
Identification of druggable hub genes and key pathways associated with cervical cancer by protein-protein interaction analysis: An in silico study.Int J Reprod Biomed202338077941PubTator, text miningPubMed
Ultrasound image segmentation based on Transformer and U-Net with joint loss.PeerJ Comput Sci202338077559PubTator, text miningPubMed
Functional graph contrastive learning of hyperscanning EEG reveals emotional contagion evoked by stereotype-based stressors.Front Hum Neurosci202338077186PubTator, text miningPubMed
Analysis of gene expression profile for identification of novel gene signatures during dengue infection.Infect Med (Beijing)202338076406PubTator, text miningPubMed
Integrated analysis of the potential roles of microRNA-messenger RNA networks in prostate adenocarcinoma.Heliyon202338076048PubTator, text miningPubMed
Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma.Cancers (Basel)202338067357PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/55872/papers?page=8